BlackRock Health Sciences Trust II (BMEZ)
Company Info
Highlights
$1.44B
$0.21
67.48
$12.28 - $15.98
0.50%
2.18
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
BlackRock Health Sciences Trust II (BMEZ) returned 5.61% year-to-date (YTD) and 10.06% over the past 12 months.
BMEZ
5.61%
1.55%
-1.13%
10.06%
6.03%
2.44%
N/A
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of BMEZ, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 15.87% | -2.69% | -5.00% | -0.19% | -1.22% | 5.61% | |||||||
| 2024 | 5.82% | 6.45% | 1.05% | -11.32% | 6.31% | 1.77% | 5.09% | 1.75% | -0.28% | -1.49% | 2.66% | -6.98% | 9.55% |
| 2023 | 8.48% | -3.24% | 6.02% | -1.90% | -2.21% | 5.18% | 0.40% | -4.59% | -5.81% | -8.56% | 7.00% | 5.99% | 5.07% |
| 2022 | -14.31% | -5.59% | -0.16% | -12.19% | -3.43% | -0.83% | 4.33% | -3.19% | -7.64% | 5.52% | 5.46% | -4.47% | -32.65% |
| 2021 | 1.18% | -5.43% | -2.90% | 5.21% | 3.43% | 2.70% | -1.45% | 1.84% | -5.64% | -0.32% | -8.71% | 5.33% | -5.76% |
| 2020 | 1.40% | -1.57% | -10.50% | 9.97% | 3.59% | 4.16% | 8.57% | 8.11% | -1.55% | -1.59% | 17.44% | 5.11% | 48.77% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BMEZ is 63, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
BlackRock Health Sciences Trust II provided a 14.75% dividend yield over the last twelve months, with an annual payout of $2.12 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Dividend | $2.12 | $1.69 | $1.58 | $1.74 | $1.71 | $0.90 |
Dividend yield | 14.75% | 11.74% | 10.81% | 11.28% | 6.75% | 3.14% |
Monthly Dividends
The table displays the monthly dividend distributions for BlackRock Health Sciences Trust II. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.18 | $0.18 | $0.18 | $0.17 | $0.17 | $0.88 | |||||||
| 2024 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $1.69 |
| 2023 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.09 | $0.09 | $0.09 | $1.58 |
| 2022 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $1.74 |
| 2021 | $0.10 | $0.10 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | $0.21 | $1.71 |
| 2020 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | $0.90 |
Dividend Yield & Payout
Dividend Yield
BlackRock Health Sciences Trust II has a dividend yield of 14.75%, which means its dividend payment is significantly above the market average.
Payout Ratio
BlackRock Health Sciences Trust II has a payout ratio of 846.82%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust II. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the BlackRock Health Sciences Trust II was 46.05%, occurring on May 11, 2022. The portfolio has not yet recovered.
The current BlackRock Health Sciences Trust II drawdown is 28.42%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -46.05% | Feb 16, 2021 | 313 | May 11, 2022 | — | — | — |
| -39.45% | Feb 12, 2020 | 25 | Mar 18, 2020 | 75 | Jul 6, 2020 | 100 |
| -9.99% | Sep 2, 2020 | 4 | Sep 8, 2020 | 19 | Oct 5, 2020 | 23 |
| -8.46% | Oct 14, 2020 | 13 | Oct 30, 2020 | 4 | Nov 5, 2020 | 17 |
| -8.29% | Jan 21, 2021 | 8 | Feb 1, 2021 | 9 | Feb 12, 2021 | 17 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust II over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of BlackRock Health Sciences Trust II, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how BlackRock Health Sciences Trust II is priced in the market compared to other companies in the Capital Markets industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for BMEZ, comparing it with other companies in the Capital Markets industry. Currently, BMEZ has a P/E ratio of 67.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BMEZ relative to other companies in the Capital Markets industry. Currently, BMEZ has a P/S ratio of 58.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BMEZ in comparison with other companies in the Capital Markets industry. Currently, BMEZ has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |